Interplay of correlations and Majorana mode from local solution perspective.

We study the quasiparticle spectrum of a hybrid system, comprising a correlated (Anderson-type) quantum dot coupled to a topological superconducting nanowire hosting the Majorana boundary modes. From the exact solution of the low-energy effective Hamiltonian, we uncover a subtle interplay between Coulomb repulsion and the Majorana mode. Our analytical expressions show that the spectral weight of the leaking Majorana mode is sensitive to both the quantum dot energy level and the repulsive potential.

Peer-to-peer validation of Ki-67 scoring in a pathology quality circle as a tool to assess interobserver variability: are we better than we thought?

Ki-67, a nuclear protein expressed in all stages of cellular proliferation, is a valuable tool to assess tumor proliferation and has been linked to more aggressive tumor behavior. However, interlaboratory staining heterogeneity and inter-observer variability challenge its reproducibility. Round Robin tests are a suitable tool to standardize and harmonize immunohistochemical and molecular analyses in histopathology.

Quench dynamics of Fano-like resonances in the presence of the on-dot superconducting pairing.

We explore the electron dynamics of a system composed of double quantum dot embedded between metallic and superconducting leads in a "T-shape" geometry. In nanoscopic systems, where electron transfer between electrodes can be realized via different paths, interference effects play an important role. For double quantum dot system in the chosen geometry, interference of electrons transferred between electrodes via the interfacial quantum dot and electrons scattered on the side dot gives rise to Fano-like interference.

Evaluation of a tryptase depletion index for better pathologic identification of mast cell activation syndrome.

Background: Laboratory evidence supporting diagnosis of the prevalent condition of mast cell activation syndrome (MCAS) currently includes elevated levels in blood or urine of mediators relatively specific to mast cells (MCs) and/or increased numbers of MCs in luminal gastrointestinal (GI) tract tissues. However, identification of elevated mediators is technically challenging and expensive, and controversy persists regarding the normal ranges of numbers/counts of MCs in various GI tract segments, let alone challenges in determining how many of the visualized MCs are activated. To aid diagnosis of MCAS, we developed a potential new approach for the pathologist to identify the extent of GI tract MC activation easily and inexpensively.

[Cystic diseases in urology : Recommendations for patients with systemic mast cell disease].

The systemic mast cell disease (MCAD; prevalence 17%) may occur frequently in urological patients. MCAD-induced changes include cysts in all organs, also in the urogenital system. In the presence of MCAD, the surgical removal of such cysts must consider specific features of the MCAD in order to reduce surgical and complication risks.